187 related articles for article (PubMed ID: 32361610)
1. Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis.
Ramesh D; Joji A; Vijayakumar BG; Sethumadhavan A; Mani M; Kannan T
Eur J Med Chem; 2020 Jul; 198():112358. PubMed ID: 32361610
[TBL] [Abstract][Full Text] [Related]
2. Syntheses of lipophilic chalcones and their conformationally restricted analogues as antitubercular agents.
Ahmad I; Thakur JP; Chanda D; Saikia D; Khan F; Dixit S; Kumar A; Konwar R; Negi AS; Gupta A
Bioorg Med Chem Lett; 2013 Mar; 23(5):1322-5. PubMed ID: 23369537
[TBL] [Abstract][Full Text] [Related]
3. Expansion of a novel lead targeting M. tuberculosis DHFR as antitubercular agents.
Sharma K; Tanwar O; Deora GS; Ali S; Alam MM; Zaman MS; Krishna VS; Sriram D; Akhter M
Bioorg Med Chem; 2019 Apr; 27(7):1421-1429. PubMed ID: 30827867
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of heterocycle structures as potential inhibitors of Mycobacterium tuberculosis UGM.
Maaliki C; Fu J; Villaume S; Viljoen A; Raynaud C; Hammoud S; Thibonnet J; Kremer L; Vincent SP; Thiery E
Bioorg Med Chem; 2020 Jul; 28(13):115579. PubMed ID: 32546296
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and
Dhivya LS; Pradeepa BR; Sarvesh S
Future Med Chem; 2022 Jun; 14(12):851-866. PubMed ID: 35548879
[No Abstract] [Full Text] [Related]
6. Pyrazole-coumarin and pyrazole-quinoline chalcones as potential antitubercular agents.
Kumar G; Siva Krishna V; Sriram D; Jachak SM
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000077. PubMed ID: 32484273
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Antimycobacterial Activity of 3-Phenyl-1
Jardim Etchart R; Rambo RS; Lopes Abbadi B; Sperotto N; Ev Neves C; Fries Silva F; Dornelles M; Duarte L; Souza Macchi F; Alberton Perelló M; Vescia Lourega R; Valim Bizarro C; Basso LA; Machado P
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500579
[TBL] [Abstract][Full Text] [Related]
9. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors.
Krishna VS; Zheng S; Rekha EM; Nallangi R; Sai Prasad DV; George SE; Guddat LW; Sriram D
Eur J Med Chem; 2020 May; 193():112178. PubMed ID: 32171154
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
Tiwari AP; Sridhar B; Boshoff HI; Arora K; Gautham Shenoy G; Vandana KE; Varadaraj Bhat G
Mol Divers; 2020 Nov; 24(4):1265-1279. PubMed ID: 31506871
[TBL] [Abstract][Full Text] [Related]
11. MoS
Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
[TBL] [Abstract][Full Text] [Related]
12. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
14. Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives.
Naidu KM; Srinivasarao S; Agnieszka N; Ewa AK; Kumar MM; Chandra Sekhar KV
Bioorg Med Chem Lett; 2016 May; 26(9):2245-50. PubMed ID: 27020525
[TBL] [Abstract][Full Text] [Related]
15. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
[TBL] [Abstract][Full Text] [Related]
16. A New Series of Pyrrole-Based Chalcones: Synthesis and Evaluation of Antimicrobial Activity, Cytotoxicity, and Genotoxicity.
Özdemir A; Altıntop MD; Sever B; Gençer HK; Kapkaç HA; Atlı Ö; Baysal M
Molecules; 2017 Nov; 22(12):. PubMed ID: 29189730
[TBL] [Abstract][Full Text] [Related]
17. Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation.
Kasetti AB; Singhvi I; Nagasuri R; Bhandare RR; Shaik AB
Molecules; 2021 May; 26(10):. PubMed ID: 34064806
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of new indole-based chalcones as potential antiinflammatory agents.
Özdemir A; Altintop MD; Turan-Zitouni G; Çiftçi GA; Ertorun İ; Alataş Ö; Kaplancikli ZA
Eur J Med Chem; 2015 Jan; 89():304-9. PubMed ID: 25462246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
